Yorktown Management & Research Company’s AstraZeneca AZN Stock Holding History

Yorktown Management & Research Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,000	Closed	-$404K	–	302
2019 Q1	$404K	Hold	5,000	–	–	0.13%	184
2018 Q4	$380K	Sell	5,000 -4,400	-47%	-$344K	0.13%	170
2018 Q3	$744K	Sell	9,400 -10,000	-52%	-$756K	0.22%	125
2018 Q2	$1.36M	Hold	19,400	–	–	0.4%	60
2018 Q1	$1.36M	Buy	19,400 +14,400	+288%	+$997K	0.4%	60
2017 Q4	$347K	Hold	5,000	–	–	0.1%	220
2017 Q3	$339K	Hold	5,000	–	–	0.09%	184
2017 Q2	$341K	Hold	5,000	–	–	0.11%	106
2017 Q1	$311K	Hold	5,000	–	–	0.08%	146
2016 Q4	$273K	Buy	5,000 +1,800	+56%	+$102K	0.07%	181
2016 Q3	$210K	Buy	+3,200	New	+$209K	0.05%	253
2016 Q1	–	Sell	-23,200	Closed	-$1.57M	–	364
2015 Q4	$1.57M	Hold	23,200	–	–	0.28%	116
2015 Q3	$1.48M	Hold	23,200	–	–	0.24%	147
2015 Q2	$1.48M	Buy	23,200 +20,000	+625%	+$1.37M	0.26%	102
2015 Q1	$219K	Hold	3,200	–	–	0.04%	411
2014 Q4	$225K	Hold	3,200	–	–	0.05%	352
2014 Q3	$229K	Hold	3,200	–	–	0.04%	360
2014 Q2	$238K	Hold	3,200	–	–	0.04%	364
2014 Q1	$208K	Sell	3,200 -800	-20%	-$51.7K	0.04%	419
2013 Q4	$237K	Hold	4,000	–	–	0.05%	326
2013 Q3	$208K	Buy	+4,000	New	+$201K	0.04%	322

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Yorktown Management & Research Company's AZN Position: Q2 2019 in Review

Yorktown Management & Research Company sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 5,000 shares — an estimated $404K sold.

Yorktown Management & Research Company first reported a position in AZN in Q3 2013 and held it in 21 quarters. The position peaked at $1.57M in Q4 2015. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Yorktown Management & Research Company reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
Yorktown Management & Research Company sold 5,000 AstraZeneca shares in Q2 2019, an estimated $404K.
Yorktown Management & Research Company first reported a position in AstraZeneca in Q3 2013 and held it in 21 quarters.
Yorktown Management & Research Company's AstraZeneca position peaked at $1.57M in Q4 2015.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Yorktown Management & Research Company's 13F filing for Q2 2019, filed 2 Aug 2019.